← All stocks

CLOVER HEALTH INVESTMENTS, CORP. /DE

CLOV Net buying
CIK 0001801170 #1978 in the set updated 17 Sep 2026
Bought (120 mo)
$13.72M
out of their own pocket, the only kind of buying there is
Sold (120 mo)
$8.82M
$6.56M on a plan · $0.00 straight out of an exercise
Sold at will
$2.26M
7 of 42 sales
Net
+$4.90M
+$11.46M against sales at will

By person

26 insiders · 59 transactions
Insider
Role
Bought
Sold
Net
Holding
Worth
Change
Palihapitiya Chamath
10% owner
$10.00M (1)
+$10.00M
42,239,130
$199.37M
+45.6%
Wai Conrad
CEO, Counterpart Health
$3.10M (5) scheduled
−$3.10M
3,625,811
$17.11M
−25.1%
Garipalli Vivek
Director
$3.00M (4)
+$3.00M
3,534,120
$16.68M
Toy Andrew
Chief Executive Officer
$2.37M (3) scheduled
−$2.37M
9,459,316
$44.65M
Priest Brady Patrick
CEO of Clover Care Services
$1.00M (3)
−$1.00M
2,040,222
$9.63M
+1,341%
Edwards Carladenise Armbrister
Director
$951.69K (2)
−$951.69K
285,432
$1.35M
Reynoso Jamie L.
CEO, Medicare Advantage
$597.63K (20) scheduled
−$597.63K
2,805,367
$13.24M
Soares Karen
Chief Legal Officer
$536.09K (5) scheduled
−$536.09K
1,607,371
$7.59M
+155.0%
Clinton Chelsea
Director
$252.53K (1)
+$252.53K
602,814
$2.85M
SHAPIRO LEE
Director
$248.07K (1)
+$248.07K
598,622
$2.83M
Loengard Anna U
Director
$218.68K (10)
+$218.68K
557,066
$2.63M
OLDAKOWSKI JOSEPH FRANK
VP OF FINANCE AND CONTROLLER
$162.02K (2)
−$162.02K
279,067
$1.32M
−10.3%
THORNTON JOSEPH CLAY
Interim CFO
$99.65K (2) scheduled
−$99.65K
1,249,526
$5.90M
+0.9%
Osborne Ian
10% owner
30,500,000
$143.96M
+510.0%
Kuipers Peter J.
Chief Financial Officer
5,758,353
$27.18M
−15.9%
Leffler Scott J.
Chief Financial Officer
4,857,303
$22.93M
+48,473%
CLOVER HEALTH INVESTMENTS, CORP. /DE entity
Chief Technology Officer
3,093,225
$14.60M
+16.6%
Martin Joseph Richards
General Counsel
2,718,857
$12.83M
Sharp Aric R
CEO of Value Based Care
2,100,665
$9.92M
Singh Prabhdeep
Chief Growth Officer
872,821
$4.12M
Kouzoukas Demetrios L.
Director
605,980
$2.86M
Robinson William G Jr
Director
597,987
$2.82M
Reses Jacqueline D
FORMER DIRECTOR
300,000
$1.42M
Tran Thomas L
Director
180,029
$849.74K
+353.6%
Ryans James
FORMER DIRECTOR
100,000
$472.00K
Wagner Joseph F.
Chief Financial Officer
25,000
$118.00K

No percentages here. These insiders hold more than one class of share between them, and the share count on file covers one of them rather than all. Dividing the two would compare different things.

Nothing of that kind in this period.

What was left out

Form 4 filings counted 289
Amendments (4/A) skipped 10
Filings about a different issuer 0
Unreadable filings 0
Joint filings 5
Sales on a Rule 10b5-1 plan 35
Sales straight out of an exercise 0
Sales at will 7
Transactions with no price 0
Shares from compensation/vesting 152,393,713
History held since 11 Jan 2021